Orit Shaked

Orit Shaked is a seasoned commercial and strategy consultant currently working at Scala Biodesign since October 2023, focusing on accelerating protein development through innovative computational solutions. In addition to roles at Immunai and Quris, Orit serves as a member of 8400 - The Health Network and previously contributed to strategic partnerships at Yeda R&D and strategic initiatives at Nucleai. As Head of Commercial Operations at CytoReason from 2017 to 2021, Orit supported pharmaceutical companies in drug development via advanced AI solutions. Prior experience includes serving as CEO of BioRap Technologies and as a board member at ITTN, enhancing technology transfer efforts in Israel. Orit holds an MBA in Industrial Management and a PhD in Medical Sciences from the Technion, along with executive education from prestigious institutions such as Harvard Business School and UC Irvine.